Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 6 (PAICSP6) is classified as a pseudogene related to key enzymes in the purine biosynthesis pathway, specifically phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazole succinocarboxamide synthetase. Pseudogenes are segments of DNA that resemble protein-coding genes but are non-functional; they typically lack the ability to encode active RNA or protein due to mutations or truncations and do not serve as therapeutic targets. - Pseudogenes are non-functional and not classified with active therapeutic targets such as enzymes, receptors, or transporters[1][2][3][6]. - The enzymes mentioned in the pseudogene's name are involved in purine biosynthesis, but the pseudogene itself does not participate in these pathways. - No literature or database evidence suggests a biological or disease relevance, drug interaction, or role as a biomarker for PAICSP6.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 6 (PAICSP6).